Speak directly to the analyst to clarify any post sales queries you may have.
The liquid medical adhesives market is advancing rapidly, driven by increasing clinical demand, evolving regulatory landscapes, and ongoing technological innovation. Strategic insights into product segmentation, supply chain strategies, and end-user priorities are critical for senior leaders navigating this dynamic sector.
Market Snapshot: Liquid Medical Adhesives Market Size and Growth
The liquid medical adhesives market grew from USD 11.51 billion in 2024 to USD 12.29 billion in 2025. With a compound annual growth rate (CAGR) of 6.60%, the market is projected to reach USD 19.21 billion by 2032. This trajectory reflects steady demand, underpinned by increased clinical applications, demographic shifts, and rising emphasis on minimally invasive care.
Scope & Segmentation
- Product Types: Acrylic adhesives, cyanoacrylate adhesives, hydrocolloid adhesives, polyurethane adhesives, silicone adhesives.
- Applications: Catheter fixation, drug delivery patches, electrode fixation, ostomy appliances, surgical wound closure.
- End Users: Ambulatory surgical centers, home healthcare, hospitals and clinics, research laboratories.
- Distribution Channels: Direct sales, distributors, online sales, retail pharmacies.
- Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
- Key Companies: 3M Company, Henkel AG & Co. KGaA, H.B. Fuller Company, Evonik Industries AG, Avery Dennison Corporation, Dow Inc., Arkema S.A., Ashland Global Holdings Inc., Nitto Denko Corporation, Scapa Group plc.
Key Takeaways for Senior Decision-Makers
- Liquid medical adhesives now play a central role in device integration and clinical workflows, supporting less invasive procedures and expanding wearable technology adoption.
- The industry is innovating with adhesive chemistries—such as hybrid polymers and biocompatible materials—to address skin sensitivity and application-specific needs.
- Procurement and purchasing decisions increasingly focus on factors beyond performance, such as patient comfort, ease of removal, and sustainability metrics.
- Distribution strategies are diversifying, blending direct sales, distributor partnerships, and online options to reach both institutional and retail buyers efficiently.
- Companies achieving competitive advantage are those integrating technical validation, clinical evidence, and regulatory alignment into their go-to-market strategies.
Tariff Impact Across the Adhesive Value Chain
Tariffs on imported raw materials and intermediates are recalibrating cost structures throughout the adhesive supply chain. Price increases on such inputs trigger shifts in supplier selection, encourage sourcing diversification, and lead to operational adaptations like nearshoring. These pressures result in greater focus on supply chain resilience and scenario planning, as participants balance pricing, quality, and regulatory requirements.
Methodology & Data Sources
This report utilizes qualitative and quantitative methods, including structured interviews with clinical experts, procurement leaders, and R&D specialists. Additional layers of validation stem from peer-reviewed technical data, regulatory documentation, and supply chain mapping, ensuring robust and actionable findings.
Why This Report Matters
- It delivers clear insight into material, clinical, and commercial trends, empowering evidence-based decisions on market entry, investment, and product development.
- Senior executives will find actionable segmentation and competitive benchmarking to inform procurement, channel, and supplier strategies.
- Risk mitigation perspectives on tariffs and supply chain vulnerabilities strengthen operational planning and resilience.
Conclusion
The liquid medical adhesives market offers diverse growth and innovation opportunities for stakeholders committed to aligning clinical value, supply chain agility, and commercial strategy. Firms prioritizing scientific rigor, user-centricity, and regulatory strength are positioned to lead this evolving landscape.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Liquid Medical Adhesives market report include:- 3M Company
- Henkel AG & Co. KGaA
- H.B. Fuller Company
- Evonik Industries AG
- Avery Dennison Corporation
- Dow Inc.
- Arkema S.A.
- Ashland Global Holdings Inc.
- Nitto Denko Corporation
- Scapa Group plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 12.29 Billion |
| Forecasted Market Value ( USD | $ 19.21 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


